logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Carboplatin/paclitaxel/pembrolizumabPneumonitis, hepatitis and increased creatinine: 3 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1853卷 / 1期
关键词:
D O I:
10.1007/s40278-021-94978-1
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:112 / 112
相关论文
共 50 条
  • [1] Carboplatin/Paclitaxel/PembrolizumabPneumonitis: case report
    Reactions Weekly, 2025, 2046 (1) : 96 - 96
  • [2] PembrolizumabPneumonitis: 3 case reports
    Reactions Weekly, 2019, 1764 (1) : 270 - 270
  • [3] PembrolizumabPneumonitis, dermatitis and hepatitis: 2 case reports
    Reactions Weekly, 2022, 1891 (1) : 246 - 246
  • [4] Atezolizumab/pembrolizumabPneumonitis and hepatitis: 2 case reports
    Reactions Weekly, 2022, 1922 (1) : 107 - 107
  • [5] Nivolumab/pembrolizumabPneumonitis: 3 case reports
    Reactions Weekly, 2017, 1647 (1) : 223 - 223
  • [6] PembrolizumabPneumonitis and acquired resistance: 3 case reports
    Reactions Weekly, 2021, 1879 (1) : 309 - 309
  • [7] PembrolizumabPneumonitis: 2 case reports
    Reactions Weekly, 2025, 2043 (1) : 338 - 338
  • [8] PembrolizumabPneumonitis: 2 case reports
    Reactions Weekly, 2018, 1700 (1) : 206 - 206
  • [9] Carboplatin/paclitaxel/pembrolizumabPancreatitis and hepatitis: case report
    Reactions Weekly, 2021, 1839 (1) : 82 - 82
  • [10] Ribavirin/sofosbuvirAnaemia and increased serum creatinine: 3 case reports
    Reactions Weekly, 2017, 1655 (1) : 218 - 218
← 12345 →